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53 Letter to the Editor
Nitric oxide in beta-thalassemia minor: what 
factors contribute?
Beta talasemi minörde nitrik oksit: hangisi katkÕ saúlar? 
To the Editor,
I read with great interest the recent publication by 
Bayraktar et al. [1] on nitric oxide (NO) in beta thalas-
semia minor. in which they reached the conclusion that 
“These findings confirm that plasma NO levels in beta-
thalassemia minor patients are decreased at the time of 
diagnosis.” Bayraktar et al. also noted the possible use-
fulness of NO level in assessing the prognosis and fol-
low-up evaluation. There are some concerns with 
respect to the findings in this study. First, NO level can 
be disturbed by many factors. For example, the under-
lying pathophysiological conditions of the studied 
patients should be discussed. Some co-disorders and 
drug usage might alter the NO level among the patients. 
In addition, differences in food intake pattern or in 
nitrate level might be another important underlying con-
dition that affects NO level [2]. Second, the quality con-
trol in laboratory analysis and sample collection must be 
addressed. Third, there is a concern regarding the pro-
posal of Bayraktar et al. regarding the correlation 
between hemolysis and NO level in the studied patients. 
Indeed, hemolysis is not common in beta thalassemia 
minor. It remains doubtful whether the included cases in 
this study were accurately classified into the beta thal-
assemia minor group.
References
1.  Bayraktar N, Erkurt MA, Aydogdu I, Baflaran Y. The levels 
of nitric oxide in beta-thalassemia minor. Turk J Hematol 
2008;25:187-9.
2.  Milkowski A, Garg HK, Coughlin JR, Bryan NS. Nutritional 
epidemiology in the context of nitric oxide biology: a risk-
benefit evaluation for dietary nitrite and nitrate. Nitric Oxide 
2009 Sep 11 [Epub ahead of print].
Author Reply
My response regarding the manuscript entitled “Ni-
tric oxide in beta-thalassemia minor: what factors con-
tribute?” is given below. 
Firstly: In our patients, there were no co-disorders 
or drug usage. Patients with acute or chronic infections, 
chronic inflammatory diseases, heart diseases, and oth-
er anemias were not included in the study. Patients with 
similar underlying pathophysiological conditions were 
selected. In all patients, blood samples were done in a 
fasting state in the morning. Thus, there were no differ-
ences in food intake pattern. 
However, nitric oxide levels can be affected by food 
intake pattern, co-disorders and drug usage [1]. 
Secondly: In all patients, blood samples were done 
in a fasting state and in the morning. Centrifuge was 
done and plasma was separated. Plasma was frozen 
(-70°C). Nitric oxide levels of all patients were measured 
together. Plasma nitrite/nitrate levels were measured 
with the Griess reaction using a spectrophotometer at 
545 nm. Nitrite (0.1M sodium nitrite in water) was mixed 
with sulfanilamide solution (1% sulfanilamide in 5% 
phosphoric acid) first, followed immediately by addition 
of NED solution (0.1% N-1-napthylethylenediamine di-
hydrochloride in water). The absorbance was measured 
within 30 minutes. 
Thirdly: Heterozygous beta-thalassemia (thalasse-
mia minor) is described as: no or mild anemia, microcy-
tosis and hypochromia, mild hemolysis manifested by 
slight reticulocytosis and splenomegaly [2]. Hemolytic 
anemia develops in direct proportion to the deficiency of 
the beta globin chain that cannot be produced in thal-
assemia sufferers [3-6]. According to these references, 
hemolytic anemia may develop, particularly in conditions 
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 Phone: +662-4132436 E-mail: wviroj@yahoo.comof physiological stress such as infection, pregnancy or surgery, 
and anemia may increase and present symptoms. Another 
possible explanation for hemolysis is the apparent decrease 
in spectrin content, including deficient or defective spectrin 
synthesis in thalassemia erythroid precursors or globin chain-
induced membrane changes that lead to spectrin dissociation 
from the membrane [7]. 
Indeed, mild hemolysis occurs in beta thalassemia minor. 
In contrast, thalassemia intermedia and thalassemia major are 
probably associated with more severe degrees of hemolysis. 
It would have been preferable if the nitric oxide levels of the 
patient group were also compared with thalassemia major pa-
tients or Hb S patients as a positive control. Our small study 
population consisted of patients diagnosed with beta thalas-
semia minor. Further studies are needed in a large number of 
patients. 
Sincerely,
Mehmet Ali Erkurt
Inonu University Medical Faculty,
Field of Hematology, Malatya, Turkey
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